ArticleJournal of cardiac failure2025
Health Care Access and Affordability for Patients With Heart Failure in Medicare Advantage vs Traditional Medicare.
Article in Journal of cardiac failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Health care access, affordability, and satisfaction following enrollment in Medicare Advantage.Health affairs scholar · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAdults with heart failure-the majority of whom are covered by Medicare-often face barriers to accessing affordable medical care and prescription medications. Medicare Advantage (MA), the private plan alternative to traditional Medicare (TM), has expanded rapidly and now covers millions of individuals with heart failure nationwide. Therefore, understanding whether access and affordability to health care differ for patients with heart failure who have coverage from MA vs TM is critically important.
methodsThis was a cross-sectional study of Medicare beneficiaries with heart failure using the Medicare Current Beneficiary Survey 2018-2022.
resultsThe study population included 1487 respondents with heart failure, corresponding to a weighted national total of 5,875,323 beneficiaries (44.4% MA, 55.6% TM). Measures of access to medical care and prescription medications were largely similar between MA vs TM beneficiaries with heart failure. However, MA beneficiaries with heart failure reported greater difficulty affording health care, including being more likely to delay care due to costs (14.1% vs 8.5%, adjusted difference [AD], 5.32 percentage points [pp]; 95% CI, 0.57pp-10.08pp) and to skip doses of medications to make them last longer (9.6% vs 6.7%; AD, 5.74pp; 95% CI, 0.90pp-10.58pp) compared with their counterparts in TM. In addition, MA beneficiaries with heart failure were less satisfied with the overall quality of their medical care (46.4% vs 56.6%; AD, -10.60pp; 95% CI, -120.71pp to -0.48pp), but more satisfied with their prescription medication coverage across three of the four measures.
conclusionsIn this nationally representative study of Medicare beneficiaries with heart failure, those enrolled in MA reported more trouble affording both medical care and prescription medications and were overall less satisfied with their care compared with those in TM. As enrollment in MA grows, policy efforts should focus on ensuring care is affordable for patients with heart failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.